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Abstract

The objective of this research is the synthesis and characterization of novel
urea and thiourea-benzimidazole derivatives and to test their biological activities.
The 17 novel compounds (57a-j), (58a-d), 62, 63 and 65 have been synthesized,
purified by different techniques such as extraction and column chromatography and
then characterized by using suitable spectroscopic techniques including 1H-NMR,
13

C-NMR, fluorescence and IR spectroscopy techniques.
The biological activity of these compounds has been studied. The

antibacterial activity was evaluated at different concentrations (µg/ ml) against 6
types of bacteria (Esherichia coli, Pseudomonas aeruginosa, Salmonella enterica,
Klebsiella pneumoniae, Staphylococcus aureus and Enterococcus fecalis). Several
compounds (57a, 57d, 57e, 57f, 57g, 57h, 57i, 58a, 58b, 58c, 62, 63 and 65) showed
activity against enterococcus 29212 and 65 showed activity against p.aereginosa
27853 and s.aureus 25923, with different concentrations ranged 37.4 - 96.3µg/ ml.
The antifungal activity of these 17 compounds has been tested against 4 types of
fungi (Fusarium solani, botrytis cinerea, thielaviopsis punctulate and neoscytalidium
dimidiatum) and they showed negative results at 250 µM.
In the photophysical study, the emission color of compound 65 has been
studied through host-guest complexes. The fluorescence of compound 65 was
switched from cyan to green upon the addition of cucurbit[7]uril of the prepared
compound above by encapsulating the benzimidazole site and then with the 8hydroxyqunioline site in compound 65. The cyan fluorescence was restored by the
addition of cadaverine due to the replacement of benzimidazole site with cadaverine
in the CB7 cavity.
Keywords: Urea, thiourea, benzimidazole, piperazine, anti-bacterial, antifungal,
host-guest complexe.
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)Title and Abstract (in Arabic

تحضير مركبات وايجاد التطبيقات البيولوجية من مشتقات اليوريا والثيوريا مع
البينزميدازول
الملخص

يهدف هذا البحث إلى تركيب مشتقات جديدة من اليوريا والثيوريا بنزيميدازول
واختبار تطبيقاتها البيولوجية .تم تركيب  17مركبا ً جديداً وتنقيتهم باستخدام التقنيات المناسبة.
كما تم استخدام الرنين المغناطيسي النووي (البروتون والكاربون) للتأكد من بنية المركبات،
باإلضافة لتقنيات التحليل الطيفي باألشعة تحت الحمراء.
تمت دراسة فاعلية المركبات التي تم تصنيعها كمضادات بيكتيريا ،حيث تم اختبارها
على  6أنواع مختلفة من البيكتيريا (اإلشريكية القولونية ،الزائفة الزنجارية ،السالمونيال
المعوية ،كليبسيال االلتهاب الرئوي ،المكورات العنقودية الذهبية والبيكتيريا المكورات العنقودية
الذهبية) .وأظهرت الدارسات أن عدد من المركبات لديه فعالية كمضادات لبيكتيريا المكورات
المعوية  ،29212ومركب  65كمضاد لبكتريا الزائفة الزنجارية  27853ولبكتريا المكورات
العنقودية الذهبية  ،25923بتركيزات مختلفة تراوحت بين  96.3 -33.4ميكروغرام  /مل .كما
تم اختبار نشاط هذه المركبات كمضاد للفطريات حيث تم دراستها على  4أنواع من الفطريات
بتركيز  250مايكرومولر ،وأظهرت الدراسات أن المركبات ليس لديها أي فعالية كمضاد
للفطريات.
تمت دراسة الخصائص الضوئية ألحد المركبات  65باستخدام تجربة ال ُمضاف-
ضيف  CB7حيث ارتبط من جهة
ضيف .تم إخماد انبعاث ضوء المركب عند ارتباطه بال ُم ِ
ال ُم ِ
البنزيميدازول و مع زيادة التركيز ارتبط من جهة الهيدروكسي كوينولين .كما تمت استعادة
انبعاث الضوء بإضافة الكادافيرين بسبب ارتباط ال CB7مع الكادافرين بدالً من البينزميدازول.
مفاهيم البحث الرئيسية :اليوريا ،الثيوريا ،البنزيميدازول ،البيبرازين ،مضاد للبكتيريا ،مضاد
للفطريات ،الفيزيائية الضوئية.
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Chapter 1: Introduction
1.1 Overview
Heterocyclic compounds are a class of cyclic organic compounds that have
one or more heteroatoms such as O, N or S. Heterocycles are found in several groups
of naturally occurring compounds (natural products). Imidazole 1, piperazine 2 and
benzimidazole 3 are heterocyclic core scaffolds widely present in many classes of
marketed drugs that exhibit large spectrum of interesting biological activities (Mantu
et al. 2016). Examples of heterocyclic compounds which are given in Figure 1,
include cimetidine 4 and omeprazole 5 which inhibit stomach acid production;
imazapic 6 is a herbicide and carbendazim 7 is a fungicide.

Figure 1: The molecular structure of imidazole 1, pyridine 2, benzimidazole 3,
cimetidine 4, omeprazole 5, imazapic 6, carbendazim 7
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In this thesis, several compound containing imidazole, benzimidazole,
piperazine, ethylenediamine, urea

and thiourea moieties

are

synthesized,

characterized and their antibacterial, antifungal activity is evaluated.
1.2 Imidazole
There are several methods for the synthesis of imidazole and its derivatives.
Example include the condensation of nitriles with 1,2- ethylene diamine followed by
the dehydrogenation with BaMnO4 (Figure 2 a) (Elderfield, 1975). The second
example is the Wallach synthesis which involves the reaction of N,Ndimethyloxamide with phosphorus pentachloride, followed by reduction with
hydroiodic acid (Figure 2 b) (Wallach & Schuelze, 1881). Other methods for the
synthesis of imidazole derivatives are also reported in recent reviews (Manocha et al.
2016).

Figure 2: a) Condensation of nitriles with 1,2-ethylene diamine b) Wallach synthesis
for imidazole derivatives

Natural

products

containing

imidazole

moiety

include

oroidin

8,

temozolomide 9 and stevensine 10 which are isolated from marine sponge (Dyson et
al. 2014; Albizati et al. 1985). On the other hand, imidazole scaffold is found in

3
several synthetic drugs such as clotrimazole 11, isoconazole 12 and butoconazole 13
which are used as antifungal drugs (Figure 3).

Figure 3: Oroidin 8, temozolomide 9, stevensine 10, clotrimazole 11, isoconazole
12 and butoconazole 13

Imidazole derivatives have important biological activities such as anti-cancer,
antifungal, antiviral, antiinﬂammatory and anti-diabetic activities (Kale et al. 2016).
This explains the intensive synthetic interest and the attention of many research
groups around the world (Romero et al. 2014).
1.3 Benzimidazole
Benzimidazole is a derivative of imidazole and plays an important role in
organic chemistry due to its high degree of chemical stability. Oxidation and
reduction of benzimidazole require vigorous conditions (Srestha et al. 2014).

4
Benzimidazole became an attractive compound and several reports containing the
synthesis of benzimidazole derivatives appeared in the literature (Salahuddin et al.
2017; Alaqeel, 2017; Akhtar et al. 2017).
The first derivatives of benzimidazole 2,5-dimethylbenzimidazole was
synthesized by Hoebrecker in 1872 following a reduction, cyclization and
aromatization reaction of 2-nitro-4-methylacetanilide (Figure 4 a) (Wright, 1951).
Another method involves the coupling of o-phenylenediamine with p-amino benzoic
acid followed by aromatization (Figure 4 b) (Panneerselvam et al. 2011).

Figure 4: (a) Scheme for synthesized 2,5-dimethylbenzimidazole, (b) Synthesis of 2substituted-1H-benzimidazoles by HCl

Due to electronic resonance, positions 1 and 2 of the benzimidazole ring are
the most important positions in terms of reactivity. Position 1 is highly reactive due
to the nucleophilicity of the nitrogen, while the carbon in position 2 is electrophilic
due to presence of two nitrogens attached to it. There are two equivalent tautomeric
forms of benzimidazole as outlined in Figure 5 (Wright, 1951).
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Figure 5: Tautomers of benzimidazole

The most notable natural benzimidazole derivative is probably N-ribosyldimethylbenzimidazole 16 (Figure 6) which works as a ligand in vitamin B12 by
binding the nitrogen atom in benzimidazole with cobalt atom in porphyrin (Srestha et
al., 2014).

Figure 6: Structure of N-ribosyl-dimethylbenzimidazole

1.3.1 Biological activity of benzimidazole derivatives
Benzimidazole bioactivities were recently reviewed by several groups around
the world (Manocha et al. 2017; Akhtar et al., 2017; Salahuddin et al. 2017;
Shrivastava et al., 2017). Compounds containing benzimidazole have been widely
used in drug development and researchers around the world are actively seeking new
uses and applications of benzimidazole.
Benzimidazole derivatives were reported to possess antimicrobial activity
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(Negi et al. 2017); for example, the synthetic compound 17 (N-(4-nitrobenzylidine)4-(1H-benzo[d] imidazol-2-yl) benzenamine) (Figure 7) shows potent antimicrobial
activity against S.epidermidis (Gram-positive bacterium), with minimum inhibitory
concentrations (MIC) of 9 µg/mL. Compound 18 (3-(4-(1H-benzo[d]imidazol-2yl)phenyl)-2(4-methoxyphenyl)thiazolidin-4-one) showed significant activity (MIC=
12 µg/mL) against both K. pneumoniae (Gram-negative bacterium) and A. niger
(fungus).

Compound

19

(1-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-3chloro-4-p-

tolylazetidin-2-one) showed significant activity (MIC = 12 µg/mL) against E. coli
bacteria (Panneerselvam & Kumar, 2011).

Figure 7: N-(4-nitro benzylidine)-4-(1H-benzo[d] imidazol-2-yl) benzenamine(17),
3-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-2(4-methoxy phenyl)thiazolidin-4-one (18)
and 1-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-3chloro-4-p-tolyl azetidin-2-one (19)

Some benzimidazole derivatives were reported to exhibit antiviral activity
such as, human cytomegalovirus (HCMV), HIV, RNA, and influenza. Maribavir 20,
an oral drug containing benzimidazole, is used to treat human cytomegalovirus

7
(HCMV) disease in stem cell/bone (Soni, 2014). It contains substitutions at the
positions 1, 2, 5 and 6. Several benzimidazole derivatives such as 21, 22, 23 and 24
have been found in several allergy drugs due to their antihistamine activity (Figure
8).

Figure 8: The molecular structure of maribavir (20), clemizole (21), emedastine (22),
mizolastine (23) and astemizole (24)

Drugs containing benzimidazole are the most common drugs used to treat
infections associated with helminthes which are common in developing countries
(Horton, 2000). In 1961, synthesis of thiabendazole 25 opened the door for more
potent antihelminthic drugs (Brown et al., 1962). Since 1960s more than twenty
antihelminthic benzimidazole compounds were used in medical and veterinary
practices (Cazajous et al., 2018). Fenbendazole 26, albendazole 27 and mebendazole
28 are examples of antihelminthic drugs (Figure 9).
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Figure 9: The molecular structure of thiabendazole 25, fenbendazole 26, albendazole
27 and mebendazole 28

Benzimidazole derivatives were also reported to exhibit anticancer activity.
Figure 10 shows nocodazole 29 (antineoplastic drug) which inhibits various cancerrelated kinases, it is type of cancer that is related to transduction process (Shrivastava
et al., 2017).

Figure 10: The molecular structure of nocodazole

Metal chelation is one of the properties that are exhibited by compounds with
activity against Alzheimer, cancer and Parkinson diseases (Drew, 2017; Flora &
Pachauri, 2010). Therefore metal chelation is usually studied for some newly
synthesized compounds. Structure 30 (Figure 11) shows a 2-(1-methyl-1-H-
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benzimidazol-2-yl)phenyl)imino)methyl) naphthol (HL1) this compound chelates
with Cu(II), and exhibits a significant inhibitory effect on lung carcinoma cancer
cells (A-549), and is more potent (IC50=16.7 µM) than the cisplatin drug (IC50 = 27.2
µM) under the same experimental conditions.

Figure 11: The molecular structure of 2-(1-methyl-1-H-benzimidazol-2yl)phenyl)imino)methyl) naphthol (HL1)

1.4 Urea chemical and application

Figure 12: The molecular structure of urea

Urea 31 (Figure 12) is a colorless, odorless natural compound produced in the
metabolism process of mammals and excreted with urine. Urea was synthesized for
the first time by Friedrich Wohler in 1828, by combining ammonium chloride and
cyanic acid (Wöhler, 1828). Another method involves the reaction between ammonia
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and carbon dioxide to form ammonium carbamate, which is dehydrated in order to
produce urea (Shibata et al. 1995) (Equation 1).

Equation 1: Synthesis of urea by ammonia and carbon dioxide

There are several ways to synthesize organic urea listed in the Equation 2.
(Zhao et al., 2016; Min, 2018). Urea is used as a fertilizer, and as livestock feed
additive. It is also used in the production of synthetic resins in as adhesives, plastics,
moldings, plywood, laminates, particleboard, coatings and textiles. Minor uses of
urea includes as rehydrating lotions, cold-compresses, deicers and diuretics.

Equation 2: General synthetic approach towards ureas
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1.4.1 Biological activity of urea derivatives
Urea is used in many marketed treatments such as ure-Na (oral treatment) to
treat hyponatremia, and carmol drug that is used to treat dermatological disorders and
dry skin. The most popular derivatives of urea are thiourea, sulphur urea, phenyl
urea, etc. Urea and its derivatives have been shown to exhibit a number of biological
activities including antibiotic, hypoglycaemic and antiatherosclerotic effect, in
addition to antitumour activities. They also could be used as sedatives, hypnotics,
and antibacterial, anticonvulsants and anticancer agents (Sikka, 2015).
The naturally-occurring urea derivative 1,3-bis (4-methoxybenzyl) urea
(MMU) extracted from plant Pentadiplandra brazzeana root showed a significant
soluble epoxide hydrolase (sEH) inhibitory effect. sEH is an enzyme found in
mammals, and plays a major role in the metabolism of endogenous lipid epoxides.
Those lipids play a role in pain, asthma and inflammation. This compound 32 (Figure
13) showed a significant sEH inhibitory activity that significantly reduce
inflammatory pain in nociceptive pain assay in rats (IC50 of 92 nM) via fluorescent
assay on human sEH (Kitamura et al., 2015).

Figure 13: The molecular structure of MMU
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1.5 Thiourea

Figure 14: The molecular structure of thiourea

Thiourea 33 (Figure 14) is one of the most important nitrogen and sulfurcontaining compounds. Despite the structural similarity between thiourea and urea,
properties of these two compounds differ significantly, mostly due to the difference
in electronegativity between sulfur and oxygen atoms.
Thiourea is synthesized by several methods including the reaction of
isothiocyanates (mustard oils) with ammonia, primary amines, or secondary amines
to produce N-alkylated thioureas 34 (Figure 15 a). Kurzer synthesized 1-(ochlorophenyl)-2-thiourea from amine and ammonium thiocyanate 35 (Figure 15 b)
(McEwen, 1991).
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Figure 15: Synthesis of Thioureas from Mustard Oils and b) Synthesis of 1-(ochlorophenyl)-2-thiourea

1.5.1 Biological activity of thiourea

Recently, thiourea proved to be useful in drug research (Shakeel et al. 2017).
It works as control of plant pathogens like Fusarium oxysporum and Penicillum
expansum. Thiourea is naturally occurring in laburnum shrubs (Nguyen, 2018).
Research revealed that urea or thiourea with 2,3-dichlorophenyl piperazine show
variation in the anti-inflammatory activity depending on the substitution group.
Compounds with halogens (Cl, F and Br) in para position on the phenyl ring or
electron withdrawing groups show high activity. Compound of structure 36 (1-(2-(4(2,3-dichlorophenyl)piperazin-1-yl)-2-oxoethyl)-3-(4-fluoropheny8l)thiourea), which
contains F as substitution group in para position gave good activity with IC50= 30
µg/mL (Figure 16) (Vardhan et al. 2017).

Figure 16: The molecular structure of 1-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)-2oxoethyl)-3-(4-fluorophenyl)thiourea
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Derivatives of thiourea have also been used to treat the excessive activity of
thyroid gland, as in methimazole 37 and propylthiouracil 38 (Chakraborty et al.
2018). It has been found in oral antibiotic drugs such as thioacetazone 39 (Shakeel et
al., 2017). Furthermore, thiourea can work as antiseptic as in Ambazone 40 (Choi &
Jee, 2015) (Figure 17).

Figure 17: The molecular structure of methimazole 37, propylthiouracil 38,
thioacetazone 39 and Ambazone 40

1.6 Piperazine
Piperazine 2 is a saturated heterocyclic organic compound that contains
two atoms of nitrogen at opposite positions, 1 and 4. Piperazine has been widely
used in the manufacture of resins, plastics, brake fluid, and pesticides. Synthesis
of piperazine could be done by combining 1,2-dichloroethane with ammonia, and
by catalyzed reaction of ethylene diamine in the presence of nickel or cobalt (Loo

15
et al. 2017). The most popular method for the synthesis of piperazine involves the
reaction of α-keto ester 41 with substituted or unsubstituted ethylenediamine 42
to produce 3,4- dehydropiperazine-2-one 43 (Figure 18) (Sebastian at al. 2003).

Figure 18: Synthesis of 3,4- dehydropiperazine-2-one 43

1.6.1 Biological activity of piperazine
Piperazine and its derivatives have important pharmacological properties,
including antihelminthic activity, antibacterial activity, antifungal activity and
antitubercular activity (Ismail et al. 2017). There are several antidepressant drugs that
contain piperazine including amoxapine 44 and trazodone 45. In addition piperazine
can be found in antihistamine drugs such as buclizine 46 and cyclizine 47 (Figure
19).
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Figure 19: The molecular structure of amoxapine 44, trazodone 45, buclizine 46 and
cyclizine 47

Piperazine derivatives also show antipsychotics activity and it include in
several antipsychotic drugs (including hallucinations, delusions and paranoia).
Examples of Piperazine derivatives drugs include fluphenazine 48, thiothixene 49,
perphenazine 50, prochlorperazine 51 and trifluoperazine 52 (Figure 20).
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Figure 20: The molecular structure of fluphenazine 48, thiothixene 49, perphenazine
50, prochlorperazine 51 and trifluoperazine 52

Piperazine and its derivatives have also been used in anthelmintic drugs
(antiparasitic drugs that treat infections of parasitic worms) (Gokbulut & Mckellar,
2018). Generally, piperazine derivatives have anthelmintic activity by paralyzing
parasites which allows the host to remove the invading organisms easily. Piperazine
in the form of piperazine citrate and piperazine hydrate is used to treat partial
intestinal obstruction caused by Ascaris worms, a disease common for children.

1.7 The aim of this project
Drug resistance problem is the ability of microbes to mutate in order to
resist the drug effect, and grow in the presence of a drug that usually will kill them.
Drug resistance problem results from overuse and misuse of antibiotics. Alexander
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Fleming pointed to the overuse of antibiotics problem in 1945. Drug resistance
problem triggered research to produce new compounds to replace the inactive drugs
(Pandurangan et al. 2017).
Based on the biological activities of the benzimidazole, piperazine, urea and
thiourea discussed earlier in this chapter, the following scheme synthesis of a series
of derivatives containing those moieties as outlined in Figure 21.
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X
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Code
57a
57b
57c
57d
57e
57f
57g
57h
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H
4-CH3
4-OCH3
3-Cl
4-Cl
4-NO2
2-F
3-F
4-F
4-CF3

O
Code
58a
58b
58c
58d

R
4-CH3
4-OCH3
3-Cl
4-Cl

Figure 21: General synthesis of benzoimidazol-carbothioamide (57a-j) and
benzoimidazol- carboxamide derivatives (58a-d)

The diversity of the proposed compounds in this scheme is evident from the
different functional groups on the phenyl ring including activating and deactivating
groups. Activating groups such as OCH3 strongly increase the electron density on the
phenyl ring by resonance effect, while CH3 weakly increases electron density on the
phenyl ring by inductive effect. On the other hand, deactivating groups such as F, Cl
and CF3 will affect the ring by decreasing the electron density making the ring less
electron rich by inductive withdrawing effect. NO2 group is a strongly electron
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withdrawing group by resonance and inductive effect. Those different functional
groups are expected to affect the biological activity of the proposed compounds.
The structure activity relationship will be further investigated, by replacing
the piperazine with ethylenediamine in order to study the possible effect of the
piperazine ring conformation. A series of compounds with ethylenediamine moiety is
outlined in Figure 22.

Figure 22: General synthesis of benzoimidazol- carboxamide derivatives (62 and 63)
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Chapter 2: Methods
2.1 Materials and Methods
Melting points were determined in open capillary tube on a Sanyo Gallenkamp MPD
350-BM 3.5 Melting Point apparatus (UK), and are uncorrected. FT-IR spectra were
recorded in a Thermo Nicolet Nexus 470 FT-IR spectrophotometer (USA). 1H NMR
and
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C NMR spectra were recorded, using Varian-400 MHz (USA), at room

temperature in CDCl3 or DMSO-d6 at 400 MHz using solvent peaks [CDCl3: 7.26
(D), 77.2 (C) ppm and DMSO-d6 2.50 (D) and 39.7 (C) ppm] as internal references.
The assignment of chemical shifts is based on standard NMR experiments (1H, 13C,
1

H-1H COSY, 1H-13C HSQC, HMBC). TLC analyses were performed on silica F254

and detection by UV light at 254 nm. Column chromatographies were performed on
silica Gel 60 (230 mesh). Chemicals and reagents were purchased from Sigma
Aldrich Chemical Co. and ACROS ORGANICS, USA. All chemicals and reagents
were used as received without further purification.
2.1.1 Synthesis of tert-butyl 4-(1H-benzo[d]imidazol-2-yl)piperazine-1carboxylate 55

A mixture of 2-chrolobenzimidazole (3.0 g, 19.6 mmol) and N-tertbutoxycarbonyl piperazine (3.7 g, 20 mmol) in 1-butanol (40 mL) was heated to
reflux overnight. After finishing, the precipitate was collected and rinsed with ether
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and dried over high vacuum to obtain tert-butyl 4-(1H-benzimidazol-2-yl)piperazine1-carboxylate (Lv et al. 2015). White solid, (m = 5.603g, 94.5%); mp 317-319 °C; Rf
= 0.8 (1:1 Ethyl acetate/ Hexane); IR (KBr, cm-1) 1650 (C=O), 3407(NH); 1H NMR
(400 MHz, CDCl3) δ 7.49 (dd, J = 5.9, 3.2 Hz, 2H), 7.15 (dd, J = 5.9, 3.2 Hz, 2H),
4.04 – 3.83 (m, 4H), 3.74 – 3.53 (m, 4H), 1.45 (s, 9H); 13C-NMR (101 MHz,
CDCl3)
Synthesis of 2-(piperazin-1-yl)-1H-benzo[d]imidazole 56

A mixture of N-Boc protected amine 55 (5.3 g, 1 eq) in dioxane (10 mL) was
added to 4M of HCl in dioxane (106 mL). The reaction mixture was stirred at room
temperature for 3h. After completion of the reaction, the precipitate was filtered and
dried under high vacuum to obtain 2-(piperazin-1-yl)-1H-benzimidazole 56 in
quantitative yield (Lv et al., 2015; Wang et al. 2015). White solid, (m = 4.82g, 96%);
mp 317-319 °C; Rf = 0.25 (Ethyl acetate),IR (KBr, cm-1) 3380 (NH);1H NMR (400
MHz, CD3OD) δ: 7.50 – 7.41 (m, 2H), 7.38 – 7.32 (m, 2H), 4.01 – 3.91 (m, 4H, 4x
Pip-H), 3.55 – 3.46 (m, 4H, 4x Pip-H).
129.72, 124.11, 111.38, 43.25, 41.92.

C NMR (101 MHz, CD3OD) δ 149.91,
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2.1.2 General synthesis of benzoimidazol-carbothioamide (57a-57j) and
benzoimidazol-carboxamide derivatives (58a-58d)

X
S
Code
57a
57b
57c
57d
57e
57f
57g
57h
57i
57j

R
H
4-CH3
4-OCH3
3-Cl
4-Cl
4-NO2
2-F
3-F
4-F
4-CF3

O
Code
58a
58b
58c
58d

R
4-CH3
4-OCH3
3-Cl
4-Cl

To a stirred solution of 2-(piperazin-1-yl)-1H-benzo[d]imidazole 56 (1.1
mmol) in dry acetonitrile (10 mL), was added excess triethylamine (460 µL, 4 mmol)
and the corresponding isothiocyanatobenzene or isocyanatobenzene (1.1 mmol).
The mixture was stirred at room temperature overnight. The solvent was removed
under vacuum, dissolved in ethyl acetate (20 mL) then washed with water. The
organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated
leaving a small quantity of solvent. Then hexane was added. The precipitate formed
was filtered and dried to obtain the desired compounds (57a-j and 58a-d).

24
4-(1H-benzo[d]imidazol-2-yl)-N-phenylpiperazine-1-carbothioamide 57a

Off white solid, (0.53 g, 86%); mp 229-231 °C; Rf = 0.74 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1530 (S=C), 3399 (NH); 1H-NMR (400 MHz, DMSO-d6)
δ 9.49 (s, 1H), 7.32-7.28 (m, 5H), 7.27 – 7.14 (m, 3H), 7.15 – 7.10 (m, 1H), 7.077.15 (m, 2H), 4.11 – 4.09 (m, 4H), 3.68 – 3.66 (m, 4H).
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C NMR (101 MHz,

DMSO-d6) δ 182.04, 155.66, 141.35, 128.48, 125.84, 124.90, 120.48, 47.66, 46.02.
4-(1H-benzo[d]imidazol-2-yl)-N-(p-tolyl)piperazine-1-carbothioamide 57b

Off white solid (m = 0.28g, 72%); mp 231-233 °C; Rf = 0.72 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1523 (S=C), 3430 (NH); 1H-NMR (400 MHz, DMSO-d6)
δ 11.53 (s, 1H), 9.37 (s, 1H), 7.33 (d, J = 8.4 Hz, 1H), 7.27 – 7.14 (m, 3H), 7.13 –
7.06 (m, 1H), 6.95 (dd, J = 5.8, 3.2 Hz, 1H), 4.16 – 3.95 (m, 4H), 3.67 – 3.47 (m,
4H), 2.28 (s, 3H).
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C NMR (101 MHz, DMSO-d6) δ 182.07, 155.98, 138.73,

134.10, 130.78, 128.96, 126.22, 126.03, 120.26, 47.63, 46.00, 21.00.
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4-(1H-benzo[d]imidazol-2-yl)-N-(4-methoxyphenyl)piperazine-1carbothioamide 57c

White solid, (0.381 g, 57%); mp 285-287 °C; Rf = 0.77 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1527 (S=C), 3413(NH); 1H-NMR (400 MHz, DMSO-d6)
δ 11.46 (s, 1H), 9.31 (s, 1H), 7.16 (d, J = 9.0 Hz, 3H), 6.86 (d, J = 9.0 Hz, 4H), 4.13
– 3.94 (m, 4H), 3.73 (s, 3H), 3.64 – 3.52 (m, 4H). 13C-NMR (101 MHz, DMSO-d6) δ
182.24, 156.92, 155.99, 134.24, 127.90, 120.22, 113.64, 55.62, 47.61, 46.10.
4-(1H-benzo[d]imidazol-2-yl)-N-(3-chlorophenyl)piperazine-1-carbothioamide
57d

Off white solid, (0.2 g, 74%); mp 248-250 °C; Rf = 0.74 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1529 (C=S), 3428(NH); 1H-NMR (400 MHz, DMSO-d6)
δ 11.56 (s, 1H), 9.54 (s, 1H), 7.46 (t, J = 2.0 Hz, 1H), 7.37 – 7.27 (m, 2H), 7.25 –
7.20 (m, 2H), 7.17 (dt, J = 7.3, 1.9 Hz, 1H), 6.95 (dd, J = 5.8, 3.2 Hz, 2H), 4.11 –
4.02 (m, 4H), 3.69 – 3.54 (m, 4H).
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C-NMR (101 MHz, DMSO-d6) δ 181.71,

155.95, 142.94, 132.55, 130.03, 125.13, 124.41, 123.92, 120.27, 47.84, 45.99.
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4-(1H-benzo[d]imidazol-2-yl)-N-(4-chlorophenyl)piperazine-1-carbothioamide
57e

Off white solid (0.532 g, 79%); mp 246-248 °C; Rf = 0.71 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1524 (C=S), 3399(NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.48 (s, 1H, NH), 9.50 (s, 1H, NH), 7.63 – 7.40 (m, J = 9.6 Hz, 1H), 7.34 (d, J =
9.4 Hz, 2H), 7.22 (dd, J = 17.7, 7.5 Hz, 1H), 6.94 (dd, J = 13.7, 7.7 Hz, 1H), 4.17 –
3.98 (m, 4H), 3.70 – 3.51 (m, 4H). 13C NMR (101 MHz, DMSO-d6) δ 181.83,
156.09, 140.36, 128.77, 128.34, 127.37, 47.78, 45.98.
4-(1H-benzo[d]imidazol-2-yl)-N-(4-nitrophenyl)piperazine-1-carbothioamide
57f

Yellow solid, (0.252 g, 91%); mp 2041-206 °C; Rf = 0.84 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1530 (C=S), 3435 (NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.63 (br s, 1H, NH), 9.96 (s, 1H, NH), 8.18 (d, J = 9.2 Hz, 2H), 7.63 (d, J = 9.1
Hz, 2H), 7.23 (dd, J = 5.4, 3.5 Hz, 2H), 6.96 (dd, J = 5.8, 3.2 Hz, 2H), 4.13 – 4.06
(m, 4H), 3.68 – 3.60 (m, 4H). 13C NMR (101 MHz, DMSO-d6) δ 181.34, 155.70,
148.15, 142.59, 128.77, 124.41, 123.18, 120.43, 48.26, 46.00.
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4-(1H-benzo[d]imidazol-2-yl)-N-(2-fluorophenyl)piperazine-1-carbothioamide
57g

Yellowish solid, (0.206 g, 80%); mp 268-270 °C; Rf = 0.8 (9:1 Dichloromethane/
Methanol)IR (KBr, cm-1) 1528 (C=S), 3458 (NH); 1H-NMR (400 MHz, DMSO-d6) δ
11.82 (s, 1H), 9.30 (s, 1H), 7.32 – 7.21 (m, 5H), 7.21 – 7.13 (m, 1H), 7.04 – 6.94 (m,
2H), 4.17 – 3.96 (m, 4H), 3.74 – 3.58 (m, 4H).
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C NMR (101 MHz, DMSO-d6) δ

182.67, 159.03, 156.58, 154.74, 151.88, 136.89, 130.56, 129.16, 129.04, 128.24,
128.17, 124.53, 124.49, 121.06, 116.26, 116.06, 112.45, 47.52, 45.97.
4-(1H-benzo[d]imidazol-2-yl)-N-(3-fluorophenyl)piperazine-1-carbothioamide
57h

White

solid,

(0.52

g,

80%);

mp

229-231

°C;

Rf

=

0.71

(9:1

Dichloromethane/Methanol) IR (KBr, cm-1) 1535 (C=S), 3410 (NH); 1H NMR (400
MHz, DMSO-d6) δ 11.58 (s, 1H), 9.55 (s, 1H), 7.33 (td, J = 8.2, 6.8 Hz, 1H), 7.26 (dt,
J = 11.2, 2.3 Hz, 1H), 7.24 – 7.19 (m, 2H), 7.16 (ddd, J = 8.1, 2.0, 0.9 Hz, 1H), 7.00
– 6.89 (m, 3H), 4.10 – 4.04 (m, 4H), 3.66 – 3.58 (m, 4H).
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C NMR (101 MHz,
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DMSO-d6) δ 181.74, 163.24, 160.83, 155.59, 143.37, 143.26, 138.21, 129.87, 129.77,
121.06, 121.03, 120.48, 112.57, 112.28, 112.04, 111.19, 110.98, 47.91, 46.14.
4-(1H-benzo[d]imidazol-2-yl)-N-(4-fluorophenyl)piperazine-1-carbothioamide
57i

Beige solid (0.64 g, 98%); mp 284-250°C; Rf = 0.78 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1569 (C=S), 3193(NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.48 (s, 1H), 9.44 (s, 1H), 7.31 (dd, J = 9.0, 5.1 Hz, 1H), 7.22 (dd, J = 17.5, 7.6
Hz, 2H), 7.14 (t, J = 8.9 Hz, 1H), 6.94 (dq, J = 14.9, 7.4 Hz, 2H), 4.28 – 3.89 (m,
4H), 3.79 – 3.50 (m, 4H). 13C NMR (101 MHz, DMSO-d6) δ 182.15, 160.91, 158.51,
155.28, 137.63, 137.60, 128.25, 128.17, 120.76, 115.21, 114.99, 47.51, 45.96.
4-(1H-benzo[d]imidazol-2-yl)-N-(4-(trifluoromethyl)phenyl)piperazine-1carbothioamide 57j

white solid, (0.248 g, 84%); mp 246-244 °C; Rf = 0.78 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1529 (C=S), 3423 (NH); 1H-NMR (400 MHz, DMSO-d6)
δ 9.73 (s, 1H), 8.95 (s, 1H), 7.66 (d, J = 8.5 Hz, 1H), 7.58 (d, J = 8.5 Hz, 1H), 7.27
(dd, J = 5.8, 3.2 Hz, 1H), 7.02 (dd, J = 5.7, 3.2 Hz, 1H), 4.20 – 4.00 (m, 4H), 3.76 –
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3.58 (m, 4H).
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C NMR (101 MHz, DMSO-d6) δ 181.78, 155.97, 145.29, 128.96,

126.26, 125.65, 125.61, 125.57, 125.53, 124.78, 124.42, 124.10, 123.78, 123.56,
120.86, 119.39, 48.02, 46.03
4-(1H-benzo[d]imidazol-2-yl)-N-(p-tolyl)piperazine-1-carboxamide 58a

Beige solid (0.335g, 55%); mp 298-300 °C; Rf = 0.74 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1637 (C=O), 3407 (NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.46 (s, 1H), 8.55 (s, 1H), 7.34 (dd, J = 13.8, 8.2 Hz, 2H), 7.21 (s, 2H), 7.06 (t, J =
8.5 Hz, 3H), 7.00 – 6.85 (m, 2H), 3.59 (dd, J = 7.1, 3.4 Hz, 4H), 3.53 (dd, J = 7.1, 3.6
Hz, 4H), 2.23 (s, 3H).
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C NMR (101 MHz, DMSO-d6) δ 156.39, 155.53, 138.22,

137.66, 131.10, 129.60, 129.20, 120.29, 118.63, 46.37, 43.57, 20.80.
4-(1H-benzo[d]imidazol-2-yl)-N-(4-methoxyphenyl)piperazine-1-carboxamide
58b

Off white solid, (0.16 g, 63%); mp 297-299 °C; Rf = 0.75 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1634 (C=O), 3467(NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.55 (s, 1H), 8.48 (s, 1H), 7.39 – 7.31 (m, 1H), 7.21 (dd, J = 5.5, 3.4 Hz, 1H), 6.94
(dd, J = 5.8, 3.1 Hz, 1H), 6.88 – 6.80 (m, 1H), 3.70 (s, 3H), 3.61 – 3.55 (m, 4H), 3.55
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– 3.49 (m, 4H). 13C NMR (101 MHz, DMSO-d6) δ 156.25, 155.66, 154.94, 133.73,
122.04, 120.30, 114.37, 113.96, 55.53, 46.35, 43.51.
4-(1H-benzo[d]imidazol-2-yl)-N-(3-chlorophenyl)piperazine-1-carboxamide 58c

White solid, (0.41 g, 63%); mp 287-289 °C; Rf = 0.68 (9:1 Dichloromethane/
Methanol), IR (KBr, cm-1) 1636 (C=O), 3434(NH); 1H NMR (400 MHz, DMSO-d6)
δ 11.46 (s, 1H, NH), 8.82 (s, 1H, NH), 7.67 (s, 1H), 7.42 (d, J = 8.8 Hz, 1H), 7.27 (t,
J = 8.1 Hz, 1H), 6.99 (d, J = 8.4 Hz, 1H), 3.63 – 3.57 (m, 4H), 3.56 – 3.50 (m, 4H).
C NMR (101 MHz, DMSO-d6) δ 156.31, 155.03, 142.50, 133.17, 130.43, 121.78,
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119.20, 118.11, 46.31, 43.58.
4-(1H-benzo[d]imidazol-2-yl)-N-(4-chlorophenyl)piperazine-1-carboxamide 58d

Off white solid (m = 0.304g, 50%); mp 287-289 °C; Rf = 0.70z (9:1
Dichloromethane/ Methanol), IR (KBr, cm-1) 1642 (C=O), 3259(NH); 1H NMR (400
MHz, DMSO-d6) δ 11.46 (s, 1H), 8.77 (s, 1H), 7.59 – 7.45 (m, 2H), 7.29 (d, J = 8.9
Hz, 1H), 7.21 (dd, J = 18.0, 7.7 Hz, 2H), 7.08 – 6.75 (m, 2H), 3.59 (dd, J = 7.1, 3.6
Hz, 4H), 3.53 (dd, J = 6.8, 3.7 Hz, 4H.
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2.1.3 tert-butyl (2-((1H-benzo[d]imidazol-2-yl)amino)ethyl)carbamate 60

A mixture of 2-chrolobenzimidazole (1.52 g, 10mmol) and tert-butyl (2-aminoethyl)
carbamate (1.74 g, 11 mmol) in 1-butanol (40 mL) was heated to reflux for 24 hours.
After finishing, the reaction was evaporated. And to the oily crude was added diethyl
ether, evaporated and the obtained solid was purified by column chromatography
using as eluyent Chlorofom/Methanol (95/5, v/v) to afford the final product tert-butyl
4-(1H-benzimidazol-2-yl)piperazine-1-carboxylate 60 (Zhu et al., 2013). Beige solid,
(2.6g, 94%); mp 164-166 °C; IR (KBr, cm-1) 1640 (C=O), 3381 (NH); 1H NMR (400
MHz, CD3OD) δ 7.28 (dd, J = 5.9, 3.2 Hz, 2H), 7.14 (dd, J = 5.9, 3.2 Hz, 2H), 3.47
(t, J = 6.0 Hz, 2H), 3.35 – 3.27 (m, 4H), 1.39 (s, 9H). 13C NMR (101 MHz, CD3OD)
δ 157.34, 152.58, 133.12, 121.88, 111.07, 78.97, 42.75, 39.37, 27.24.
2.1.4 N1-(1H-benzo[d]imidazol-2-yl)ethane-1,2-diamine 61

A mixture of N-Boc protected amine 60 (0.4 g,1.5 mmol) in dioxane (4 mL) was
added to 4M of HCl in dioxane (8 mL). The reaction mixture was stirred at room
temperature for 3 hours. After finishing, the solvent was evaporated and wash it with
hexane

and

dried

under

high

vacuum

to

obtain

N-(2-aminoethyl)-1H-
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benzo[d]imidazol-2-amine 61 in quantitative yield. White solid, (m = 0.263g, 73%);
mp 295-297 °C; IR (KBr, cm-1) 3404(NH);
2.1.5 General synthesis of benzoimidazol-carbothioamide (62) and
benzoimidazol- carboxamide derivatives 63

A mixture N-(2-aminoethyl)-1H-benzo[d]imidazol-2-amine 61 (1eq) and
isocyanatobenzene and isocyanatobenzene (1eq) in acetonitrile (10 ml) and
Triethylamine (6 eq) stirred on ice (0◦C) overnight. After finishing, the solvent was
evaporated and extracted with ethyl acetate (20 ml). The organic phase was
evaporated, and diethyl ether was added. And the product was obtained.
1-(2-(1H-benzo[d]imidazol-2-ylamino)ethyl)-3-p-tolylurea 62

Beige solid (m = 0.069g, 77%); mp 100-102; IR (KBr, cm-1) 1705 (C=O), 3370(NH);
1

H NMR (400 MHz, CD3OD) δ 8.33 (s, 1H), 7.38 – 7.31 (m,, 2H), 7.26 – 7.19 (m,

2H), 7.18 – 7.11 (m, 2H), 7.10-7.08 (m, 1H), 7.08 – 7.01 (m, 3H), 6.42 (s, 1H), 3.573.54 (m, 2H), 3.50-3.47 (m, 2H), 2.24 (s, 3H).
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1-(2-(1H-benzo[d]imidazol-2-ylamino)ethyl)-3-p-tolylthiourea 63

Beige solid (m = 0.182g, 97%); mp 165-167,

IR (KBr, cm-1) 1684 (C=S),

3271(NH); 1H NMR (400 MHz, Methanol-d4) δ 9.32 (s, 1H), 7.45 (s, 1H), 7.33-7.31
(m, 2H), 7.24 – 7.21-7.19 (m, 2H), 7.12-7.10 (m, 2H), 7.04-7.02 (m, 2H), 3.94 – 3.87
(m, 2H), 3.64-3.61 (m, 2H), 2.27 (s, 3H).
2.1.6 Biological activity
2.1.6.1 Antibacterial activity
Measurement of minimum inhibitory concentration (MIC) by agar dilution
The compounds (57a-j), (58a-d), 62, 63 and 65 were tested toward different
types of bacteria. They dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich,
France) in concentration of 2500µM. Ten step serial dilution of this solution was
prepared in Mueller Hinton Broth (Himedia Laboratories, Mumbai, India) resulting
in concentrations of 1250, 625, 312.5, 156.25, 78.125, 39.1, 19.5, 9.8 and 4.9µM of
each compounds. One ml from each solution was added to 24 ml of molten Mueller
Hinton Agar (MHA) (MAST, Merseyside, UK) in order to prepare MHA containing
100, 50, 25, 12.5, 6.25, 3.125, 1.6, 0.8, 0.4 and 0.2µM of each compounds tested.
Furthermore, plates containing only DMSO corresponding to the DMSO
concentration of each dilution were also used as control.
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The effects of compounds were tested on the following bacteria: Esherichia
coli ATCC25922, Pseudomonas aeruginosa ATCC27853, Salmonella enterica sv.
Braenderup H9812 (ATCC BAA-664), Klebsiella pneumoniae ATCC700603,
Staphylococcus aureus ATCC25923 and Enterococcus fecalis ATCC29212.
Bacterial suspension containing approximately 104 CFU/ml were prepared in
phosphate buffered saline, of which a 10 µl drop (approximately 100 bacterial cell)
was placed on the surface of MHA plates containing the above described
concentrations of the chemical compounds tested. A MHA plate without any
chemicals was used as a growth control in each experiment. Plates were incubated
for 18 hours at 37°C in a humidified atmosphere of ambient air. The bacterial growth
after this incubation was checked and recorded.
2.1.6.2 Antifungal activity
In-vitro evaluation of some synthetic chemical compounds on the mycelial
growth of some selected plant diseases causal fungi:

The evaluation of the synthetic chemical compounds (57a-j), (58a-d), 62, 63
and 65 are in-vitro evaluated on the mycelial growth (mm) of four selected fungi
(Fusarium solani, Neocystalidium dimediatum, Botrytis cinerea, and Thielaviopsis
punctulata). The 17 compounds were dissolved in dimethyl sulfoxide (DMSO) in
concentration of 100µM.
The potato dextrose agar medium (PDA) supplied with 1ml of antibiotic
(Chloramphenicol 50mg/ml) to inhibit the bacterial growth was prepared, autoclaved
and poured into sterile petri dishes. Then the selected fungi were grown on the above
mentioned medium and incubated at 27ºC for 7 days.
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Moreover, holes of about 10-mm were made on newly prepared PDA
medium using sterile cork-borer (4 holes were made per each petri plate dish), and
then 0.2 ml from each compound was poured in each hole, and incubated in the
refrigerator (4ºC) for one hour. A sterile cork-borer (5-mm in diameter) was used to
introduce the tested pathogens on the middle of each petri-dish plate contains the
selected synthetic chemical compounds. Finally, all petri-dish plates were kept in the
incubator for 7 days at 27ºC.
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Chapter 3: Results and Discussion

3.1 Synthesis of urea and thiourea-benzimidazole derivatives with piperazine
linker
Compounds synthesized in this project (57a-57j), (58a-58d), 62, 63 and 65
are hybrid compounds of benzimidazole, piperazine, ethylenediamine and urea or
thiourea as outlined in Figures 23 and 24. Our aim is to study the effect of structural
variation (oxygen with sulfur in urea vs. thiourea) and the effect of substituents on
the benzene ring attached to their moieties on the bioactivity of these compounds.
Substituents on the benzene ring were selected based on their electronic properties
including groups that are electron donors through inductive effect (e.g –OCH3) and
groups that are electron acceptors through the resonance effect and electron
withdrawing through the inductive effect (e.g CF3). The nitro group (NO2) is electron
acceptor through inductive and resonance effect. All these structural changes are
expected to provide good understanding of the effect electronic properties have on
the bioactivity properties of these compounds. The synthesis of piprazine–urea and
thiourea derivatives is outlined in Figure 21.
3.1.1 Synthesis of key intermediate (56)
The original plan for the synthesis of key intermediate 56 was outlined in
Figure 21. However, several attempts to affect this synthesis resulted in the dimer 67
as the side product (Figure 23).
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Figure 23: Synthesis of key intermediate 57 and dimer 63

Therefore N-Boc piprazine (tert-butyloxycarbonyl protecting group) was used
to in order to get the desired product N-Boc piperazine-benzoimidazole 55.
Compound 55 was obtained from 2-chloro-benzoimidazole 53 by nucleophilic
aromatic substitution of the chlorine atom with N-Boc piperazine 54 in butanol
accordance to previously published method (Lv et al., 2015), as a white solid with a
good yield (94%) (Figure 24).

Figure 24: Synthesis of tert-butyl 4-(1H-benzo[d]imidazol-2-yl) piperazine-1carboxylate 55
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Subsequent removal of the N-Boc moiety was performed with two different
procedures (a) and (b), (Figures 25 and 26).

Figure 25: Synthesis of key intermediate 56 (method a)

The first method (Figure 25) involves the use of trifluoroacetic acid in
dichloromethane for two hours. This reaction gave the product 2-(piperazin-1-yl)1H-benzo[d]imidazole (56) with very low yields. Modification of the reaction
conditions (increasing the amount of acid and increasing reaction time) did not
improve the yield appreciably.
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Figure 26: Mechanism of key intermediate 56 (method b)

The second method (Figure 26) involves HCl in 1,4-dioxane for two hours,
this reaction gave high yield (90%) of the key intermediate 56, which was confirmed
using 1H NMR and 13C NMR spectroscopy, this method is more efficient, and it have
been used in next step to produce the final products.
3.1.2 Synthesis of urea and thiourea-piperazine benzimidazole (57a-57j) and
(58a-58d)
A series of 14 novel Benzoimidazol-carbothioamide (57a-57j) and
benzoimidazol-carboxamide derivatives (58a-58d) were synthesized as outlined in
Figure 21, were obtained by the nucleophilic addition in which the amine group in
key intermediate (56) react with the electrophilic carbon of in isothiocyanatobenzene
(S) or isocyanatobenzene (O) in the presence of acetonitrile, according to reported
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procedure. Final products (57a-j) and (58a-d) were obtained with good yields (50% 63%) and (57% - 98%) for urea and thiourea compounds, respectively. Figure 27
shows the mechanism of the reaction.

X
S
Code
57a
57b
57c
57d
57e
57f
57g
57h
57i
57j

R
H
4-CH3
4-OCH3
3-Cl
4-Cl
4-NO2
2-F
3-F
4-F
4-CF3

O
Code
58a
58b
58c
58d

R
4-CH3
4-OCH3
3-Cl
4-Cl

Figure 27: Synthesis of benzoimidazol-carbothioamide (57a-j) and benzoimidazolcarboxamide derivatives (58a-d)

41
3.1.2.1 Thiourea-piperazine benzimidazole derivatives (57a-j)
The suggested structures of compounds 57a-j were confirmed based on the
spectral results from 1H NMR,

13

C NMR and IR. In 1H NMR spectra of the

synthesized compounds 57a-j the benzimidazole protons appeared around 7 ppm and
7.2 ppm. The piperazine protons appeared around 3-3.6 ppm and 4- 4.6 ppm. While
the H-N in benzimidazole appeared at high ppm around 9. However the N-H in
thiourea it more deshield and appeared at 11.5 ppm.
The proton signals of benzene in thiourea derivatives appeared at aromatic
region as a typical two doublets with different ppm in the range of 7.00-7.50 ppm
depending on the nature of R group. While the two compounds 57j and 57f have
more downfield peaks, the peaks for 57j appeared in the range of 7.5-8.00 ppm due
to the CF3 group on aromatic ring and compound 57f appeared in the range of 7.08.50 due to the nitro group.
The

13

C NMR spectra of compounds 57a-j showed the exact number of

carbon atoms. The carbon of piperazine appeared around 46 ppm and 48 ppm,
quaternary carbon of thiourea around 181.6 ppm. The methyl in compound 57c
appeared at 55.62, while compound in 57b appeared at 20 ppm, depending on the R
group attached to benzene ring. If the R is electron-donating (57a, 57b and 57c), the
aromatic region will be in the range of 110-140 ppm. On the other hand, the
compounds 57d-j the electron-withdrawing groups is shifting the δ-value down field
to the range of 110-160 ppm. The quaternary carbon of thiourea around 181.6 ppm.
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The IR spectra of compounds 57a-j showed N-H band around 3399-3458
cm1. The thiourea is confirmed by bands around 1523-1535 cm-1 which is the C=S
stretching bands.
3.1.2.2 Urea-piperazine benzimidazole derivatives (58a-d)
The structures of compounds 58a-d were confirmed by spectral results from 1H
NMR, 13C NMR and IR.
The 1H NMR spectra of compounds 58a-d showed the same peaks of
benzimidazole in thiourea which around is 7ppm and 7.2 ppm. The peaks of
piperazine protons appeared in the range of 3.6-4.1 ppm. The H-N in benzimidazole
appeared around 9 ppm. While the N-H in urea is more deshield and appeared at 11.5
ppm. The methyl in compound 58a and 58b appeared at 2.3 ppm and 3.7ppm
respectively.
The aromatic region showed the proton of benzene that attached to urea
derivatives as a typical two doublets with different ppm in the range of 7.00-7.50
ppm depending on the R group. While the two compounds 58c and 58d showed
slightly downfield peaks in the range of 7.00-7.70 ppm due to the electronwithdrawing effect of the Cl atom.
The

13

C NMR spectra of compounds 58a-d showed the exact number of

carbon atoms. The carbon of piperazine appeared around 43 ppm and 46 ppm,
quaternary carbon of urea at 155 ppm. The methyl in compound 58a appeared at 20
ppm, while compound in 58b appeared at 55.62 ppm due to the Oxygen in the
methoxy group. Depending on the R group attached to benzene ring. If the R is
electron-donating (58a and 58b), the range of aromatic region will be 110-140 ppm.
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While the electron-withdrawing groups shifting the δ-value down field to the range
of 110-160 ppm. The quaternary carbon of urea at 155 ppm.
The IR spectra of compounds 58a-d showed N-H band around 3259-3407
cm-1. The urea is confirmed by bands around 1636-1642 cm-1 which is the C=O
stretching bands.
3.2 Synthesis of urea and thiourea-benzimidazole derivatives with
ethylenediamine linker
The structural similarity between the synthesized series carbothioamide (57a57j) and (58a-58d) required that another series of compounds to be synthesized
including compounds having ethylenediamine linker in place of the piperazine linker
as outlined in the following Figure 28.

Figure 28: General synthesis of benzoimidazol- carboxamide derivatives (62-63)

The series including piperazine moiety is presumed to have a more rigid
configuration

compared

to

those

having

the

configurationally

flexible
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ethylenediamine moiety. Ethylenediamine is less nucleophilic because it is primary
amine comparing to piperazine which is secondary amine.
3.2.1 Synthesis of key intermediate (61)
Starting with 53 and ethylenediamine, the result is a mixture of desired
product 61 and the dimer 69 (Figure 29).

Figure 29: Synthesis of key intermediate 61 and dimer 69

Therefore, N-Boc ethylene diamine (tert-butyloxycarbonyl protecting group),
was used instead. Compound 60 was obtained from 2-chloro-benzoimidazole 53 by
nucleophilic substitution of the chlorine atom with N-Boc ethylene diamine 59 in
accordance with previously published method (Zhu et al., 2013). Figure 30 shows the
mechanism of the reaction.
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Figure 30: Synthesis of tert-butyl (2-((1H-benzo[d]imidazol-2yl)amino)ethyl)carbamate 60

In this step ethylenediamine takes longer time to react with protecting group
which shows a lower yield than the reaction of piprazine compound with protecting
group. This because the ethylenediamine is primary amine which make it less
nucleophile comparing with the piprazine (secondary amine).
The crude oily product was first solidified by diethyl ether and purified by
column chromatography (eluent chloroform/methanol (95/5, v/v)). Subsequent
removal of the N-Boc moiety with 4M HCl in dioxane gave 2-(aminoethyl)-1Hbenzo[d]imidazol-2-amine (61) with yields (73%) (Figure 31).

46

Figure 31: Mechanism of key intermediate 61

3.2.2 Synthesis of urea and thiourea-piperazine ethylenediamine.
Compounds 62 and 63 were synthesized as outlined in Figure 30, they
obtained by the nucleophilic addition in which the amine group in key intermediate
(61) react with the electrophilic carbon of in isothiocyanatobenzene (S) or
isocyanatobenzene (O) in the presence of acetonitrile, according to reported
procedure in experimental part. Figure 32 shows the mechanism of the reaction.
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62

63

70

71

72

73

74

X

O

S

O

O

O

S

S

R

4-CH3

4-CH3

4-NO2

3-Cl

4-OMe

3-Cl

H

Figure 32: Synthesis of benzoimidazol- carboxamide derivatives

The synthesize compounds 62-74 was attempted by the reaction of key
intermediate, (61) with isothiocyanatobenzene and isocyanatobenzene respectively.
Two out of the seven compounds 62 (urea) and 63 (thiourea) with a substituent group
(-CH3) were obtained in good yield 95% and 77%, respectively. Those products were
pure and their structures were confirmed using 1H NMR and 13C NMR.
Compounds (70-74) were achieved with lower yields and purities. Repeated
recrystallization with several solvents and preparative TLC did not achieve the
desired purity criterion. Therefore, these compounds have not been pursued for
synthesis and purification.
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3.2.2.1 1-(2-(1H-benzo[d]imidazol-2-ylamino)ethyl)-3-p-tolylurea 62
The suggested structures of 62 were confirmed based on the 1H NMR,

13

C

NMR and IR results. 1H NMR spectrum shows the signals of ethylenediamine at 3.4
ppm and 3.5 ppm. The methyl group appeared at low ppm 2.24. In the aromatic
region the proton signals of benzene that attached to urea derivative appeared in the
range of 7.20-7.30 ppm. While signals of benzimidazole group appeared around 7
ppm and 7.2 ppm. The IR spectra showed N-H band at 3370 cm-1. The urea is
confirmed by bands at 1705 cm-1 which is the C=O stretching bands.
3.2.2.2 1-(2-(1H-benzo[d]imidazol-2-ylamino)ethyl)-3-p-tolylthiourea 63
The structures of 63 were confirmed based on the spectral results of 1H NMR,
13

C NMR and IR results. In the 1H NMR spectrum the signals of ethylenediamine

appeared at 3.6 ppm and 3.9 ppm. The methyl group appeared at low ppm 2.27. In
the aromatic area the signals of benzimidazole group appeared around 7 ppm and 7.2
ppm. While signals of benzene that attached to urea derivative appeared in the range
of 7.20 -7.40 ppm. The IR spectrum showed N-H band at 3271 cm-1. The urea is
confirmed by bands at 1684 cm-1 which is the S=O stretching bands.
3.3 Biological activity
3.3.1 Antibacterial activity
Measurement of minimum inhibitory concentration (MIC) by agar dilution
method
Compounds (57a-57j), (58a-58d), 62, 63 and 65 were tested for antibacterial
activity using the agar dilution method against six types of resistance gram positive
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and gram negative bacteria including E.coli 25922, P.aereginosa 27853, Salmonella
H9812, K.pneumoniae 700603, S.aureus 25923 and Enterococcus 29212.
E.coli is a gram negative bacterium that causes of the gastrointestinal tract
and central nervous system (Kaper et al. 2004). P.aereginosa is a gram negative
bacteria able to cause nosocomial infections such as wound infections and urinary
tract infections (Rustini et al. 2017). Salmonella is a gram negative bacteria and it is
the second predominant cause of foodborne gastroenteritis (Mahmoud, B., 2012).
K.pneumoniae is a gram negative bacteria that causes nosocomial infections,
pneumonia, and sepsis in patients (Mei et al. 2017). S.aureus is a gram positive
bacterium that causes both community-acquired and hospital infections such as
meningitis and pneumonia (Bacci & Boncompain, 2017). Enterococcus it is a gram
positive bacteria that cause line-associated bloodstream infections (Woods et al.
2007). Those pathogens are considered as life-threatening bacteria and they innate
resistance to many antibiotics which make them target for many research groups.
Table 1 shows the MIC (µg/ml) results of the 17 compounds tasted against
the 6 bacteria. 13 out of 17 compounds showed a good to moderate activity against
enterococcus 29212 at different concentrations ranged between 37.1 – 92.7 µg/ml. In
addition 2 compounds (65 and 57e) out of the 13 compounds showed a moderate
activity against the S.aureus 25923 (gram positive bacteria) with concentration 88
µg/ml and 92.7µg/ml respectively. While bacteria P.aereginosa 27853 has been
inhibited by compound 65 and 57e with concentration 88 µg/ml and 92.7 µg/ml,
respectively. The rest 4 compounds showed negative results against the 6 type of
bacteria.
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E.coli

P.aereginosa

Salmonella

K.pneumoniae

S.aureus

Enterococcus

Table 1: MIC (µg/ml) of compounds (57a-57j), (58a-58d), 62, 63 and 65

DMSO

GROWING

GROWING

GROWING

GROWING

GROWING

GROWING

57a

>83.6

>83.6

>83.6

>83.6

>83.6

66.9

57b

>88

>88

>88

>88

>88

>88

57c

>92.7

>92.7

>92.7

>92.7

>92.7

>92.7

57d

>89

>89

>89

>89

>89

71.3

57e

>92.7

92.7

>92.7

>92.7

92.7

92.7

57f

>96.3

>96.3

>96.3

>96.3

>96.3

77

57g

>89

>89

>89

>89

>89

71.3

57h

>89

>89

>89

>89

>89

71.3

57i

>89

>89

>89

>89

>89

89

57j

>101.8

>101.8

>101.8

>101.8

>101.8

>101.8

58a

>83.6

>83.6

>83.6

>83.6

>83.6

66.9

58b

>88

>88

>88

>88

>88

70.4

58c

>92.7

>92.7

>92.7

>92.7

>92.7

37.1

58d

>89

>89

>89

>89

>89

>89

62

>78.2

> 78.2

>78.2

> 78.2

>78.2

78.2

63

> 61.8

> 61.8

> 61.8

> 61.8

> 61.8

49.4

65

>88

88

>88

>88

88

88

2-Cl BZ

> 38.1

> 38.1

> 38.1

> 38.1

> 38.1

> 38.1

8-HQ

29

> 36.2

36.2

29

14.4

> 36.2

MHA

GROWING

GROWING

GROWING

GROWING

GROWING

GROWING
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3.3.2 In vitro Antifungal activity
In vitro -evaluation of the minimum effective concentration in vitro
Compounds (57a-57j), (58a-58d), 62, 63 and 65 were tested against 4 types of
fungi which are Fusarium solani, botrytis cinerea, thielaviopsis punctulate and
neoscytalidium dimidiatum.
Fusarium solani is a fungus that causes blindness in subtropical and tropical
areas (Zwart et al. 1973). Botrytis cinerea is a fungus responsible of gray mold
disease on over 200 plants and kills the host plant through the production of reactive
oxygen species and toxin (Choquer et al. 2007). Thielaviopsis punctulate is a type of
fungus that causes serious diseases on date palm such as black scorch and rhizosis,
which could affect the economic value of these trees (Saeed et al. 2016).
Neoscytalidium dimidiatum is a mold that causes dermatomycosis, onychomycosis,
and pulmonary fungal infection (Dionne et al., 2015).
The 17 compounds were tested at 100 µM concentration, after 10 days in this
incubation the fungus growth was checked and recorded. In the plates of compounds
and control (DMSO) the fungi grow normally, therefor compounds did not show
antifungal activity at ≥ 100 µM (Table 2).
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Table 2: MIC of compounds (57a-57j), (58a-58d), 62, 63 and 65
Fusarium
solani

botrytis
cinerea

thielaviopsis
punctulate

neoscytalidium
dimidiatum.

DMSO

GROWING

GROWING

GROWING

GROWING

57a

>100µM

>100µM

>100µM

>100µM

57b

>100µM

>100µM

>100µM

>100µM

57c

>100µM

>100µM

>100µM

>100µM

57d

>100µM

>100µM

>100µM

>100µM

57e

>100µM

>100µM

>100µM

>100µM

57f

>100µM

>100µM

>100µM

>100µM

57g

>100µM

>100µM

>100µM

>100µM

57h

>100µM

>100µM

>100µM

>100µM

57i

>100µM

>100µM

>100µM

>100µM

57j

>100µM

>100µM

>100µM

>100µM

58a

>100µM

>100µM

>100µM

>100µM

58b

>100µM

>100µM

>100µM

>100µM

58c

>100µM

>100µM

>100µM

>100µM

58d

>100µM

>100µM

>100µM

>100µM

62

>100µM

>100µM

>100µM

>100µM

63

>100µM

>100µM

>100µM

>100µM

65

>100µM

>100µM

>100µM

>100µM
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Chapter 4: Photochemistry
4.1 Introduction
Luminescence is the emission of visible, ultraviolet or infrared photons by
some substances in their excited states upon the exposure to a light source at a
shorter wavelength (Lakowicz, 2006). It is divided into two types depending on the
route of deactivation of the energy at the excited state, namely, fluorescence and
phosphorescence (Valeur & Santos, 2001). The environment plays an important role
in modulating the ﬂuorescence emission originated from some organic molecules, so
called fluorescent probes, which are used to report information about the structure
and dynamics of the surrounding microhetergenous systems, such as biological
receptors in medicinal applications (Shaikh et al. 2008). Fluorescent dyes can be used
to relocate and detect some biological substrates in cellular media, micelles,
membranes, polymers, and more (Hamilton et al. 2015). In many occasions, hostguest complexes of several fluorescent probes were employed in biological
application (Dsouza et al. 2011).
Supramolecular photochemistry was first developed by Lehn, Cram and
Pedesen in 1987. Since then this field has seen an evolution in different application
such as biomedicine and chemical sensing (Saleh et al. 2013). Supramolecular
photochemistry is the study of the properties of molecular assemblies through
intermolecular interactions in their excited states (Ramamurthy & Mondal, 2015).
Supramolecular chemistry is the study of host-guest complexes (Dsouza et al. 2011),
which occurs when a small molecule (guest) inters the cavity of a larger molecule
(host) and interact by non-covalent bonds (Wagner, 2009). The non-covalent
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interactions are hydrogen bonding, electrostatic interaction, cation- π and anion-π
interaction, hydrophobic interaction, and other aromatic interaction (Shumilova et al.
2018).
Cucurbit[n]urils (CBn) consisted of glycoluril group that are connected to
methylene groups. The applications of cucurbit[n]urils complexes in supramolecular
chemistry has come into a form of stable complexes with different guests, including
amino acids, drug molecules, dyes, saccharides, hydrocarbons, and proteins, which
have number of applications in health, environment and energy (Assaf & Nau, 2014).
Figure 33 represents cucurbit[n]urils structures, including three examples: CB5, CB6
and CB7.

Figure 33: Chemical structure of cucurbiturils molecular containers (CB5, CB6 and
CB7)

Based on the important and applications of the fluorescent dyes and
supramolecular photochemistry as discussed earlier in the introduction, compound 65
was selected and the binding properties of the fluorescent dye with CB7 was tested
by the titration method using NMR and UV-Vis techniques.
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4.2 Experimental part
4.2.1 Chemistry
4.2.1.1 Preparation of 5-chloromethyl-8-quinolinol hydrochloride 64

A mixture of 8-hydroxyquine (5.84 g, 70.0 mmol), with zinc chloride (1.05 g, 29.6
mmol) in 50 ml of concentrated hydrochloric acid, and 6.4 ml of 37% formaldehyde
was stirred overnight. The mixture was filtered, washed with acetone and dried to
obtain the desired compounds. The yellow solid obtained (7.94g, 86%). 1H NMR
(400 MHz, Deuterium Oxide) δ 9.06 (dd, J = 8.7, 1.4 Hz, 1H), 8.81 (dd, J = 5.4, 1.4
Hz, 1H), 7.90 (dd, J = 8.7, 5.4 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.18 (d, J = 8.0 Hz,
1H), 4.87 (d, J = 0.6 Hz, 2H). 13C NMR (101 MHz, D2O) δ 145.96, 143.02, 141.86,
129.99, 127.84, 127.36, 127.15, 121.70, 115.05, 59.77.
4.2.1.2 Synthesis of 5-((4-(1H-benzo[d]imidazol-2-yl)piperazin-1yl)methyl)quinolin-8-ol 65
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To a stirred solution of 2-(piperazin-1-yl)-1H-benzo[d]imidazole 56 (0.5 mmol) in
tetrahydrofuran (10 mL), triethylamine (460 µL, 4 mmol) was added 5-chloromethyl8-quinolinol hydrochloride 64 (0.5 mmol). The mixture was stirred at room
temperature overnight. After completion, the solvent was removed under vacuum,
dissolved in ethyl acetate (20 mL) then washed with water. The organic layer was
dried over anhydrous sodium sulfate, the solvent was evaporated, the crude was
crystalized over ethyl acetate and the precipitate formed was filtered and dried to
obtain the desired compounds. White solid, (0.115 g, 63%); mp 276-278 ⁰C; Rf =
0.44 (Ethyl acetate) IR (KBr, cm-1) 3077(NH), 3326 (OH); 1H NMR (400 MHz,
DMSO-d6) δ 11.34 (s, 1H), 9.76 (s, 1H), 8.86 (dd, J = 4.1, 1.6 Hz, 1H), 8.69 (dd, J =
8.6, 1.7 Hz, 1H), 7.60 (dd, J = 8.6, 4.1 Hz, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.16 (dd, J
= 18.9, 7.6 Hz, 2H), 7.01 (d, J = 7.7 Hz, 1H), 6.97 – 6.84 (m, 2H), 3.83 (s, 2H), 3.43
(t, J = 5.0 Hz, 4H), 2.53 (d, J = 4.3 Hz, 4H). 13C NMR (101 MHz, DMSO) δ 156.49,
153.41, 148.24, 139.32, 134.27, 129.52, 128.34, 124.21, 121.93, 110.43, 60.04,
52.36, 46.47.
4.2.2 Photochemistry
4.2.2.1 Binding titration experiment
Samples: CB7 (purity < 99.9%) was purchased from sigma-Aldrich
UV−vis absorption spectra and fluorescence spectra were measured by Cary300 instrument (Varian) and Cary-Eclipse instrument respectively with slit widths 10
nm for both the excitation and emission monochromator or 5 nm and 10 nm for
excitation and emission monochromator. In the titration experiment, the
concentrations of the guest were kept constant and the host was gradually increased.
The spectra were plotted as a function of the host concentrations at a given
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wavelength. In the binding experiment of compound 65 with CB7, the following
procedure was used at pH 7.4; 35 µM of 65 solution was placed in cuvette with 1-cm
optical path length and small amounts of the CB7 solution (1 mM) were gradually
added with micropipette. For theinteraction of 65/CB7 complex with CAD at pH 7.4,
and 35 µM of 65 and 350 µM of CB7 solution was placed in the same cuvette and
small amounts of the CAD solution (1 mM) were gradually added with micropipette
(Saleh et al. 2015).
4.2.2.2 NMR titration
All 1H NMR spectra were recorded, using Varian-400 MHz (USA), at room
temperature in D2O. The pH values of the solutions were adjusted by adding HCl
(DCl) and recorded using a pH meter (WTW 330i equipped with a WTW SenTix
Mic glass electrode). For the NMR titration experiment of compound 65 with CB7
complex, first the pD of D2O was adjusted to 2.9 in which a stock solution of 65 was
prepared with a ﬁnal concentration of ~2 mM. Then a calculated weight of CB7 (0.2
equivalent) was added to compound 65 solution in the NMR tube. The 0.2 equivalent
of CB7 were gradually added to the solution to complete the titration. The NMR
spectra were measured for each solution (Saleh et al. 2015).
However, for the titration experiment of 65/CB7 complex with CAD at pH
1.3, a stock solution of 65 (2 mM) and CB7 (4 mM) complex was prepared. Then a
calculated weight of CAD (1 equivalent) was added to the complex in the NMR tube.

58
4.3 Results and discussion
4.3.1 Chemistry
4.3.3.1 Synthesis of 5-((4-(1H-benzo[d]imidazol-2-yl)piperazin-1yl)methyl)quinolin-8-ol (65)
Compound 65 was prepared by SN2 reaction of 5-chloromethyl-8-quinolinol
hydrochloride 64 with the key intermediate 56, in the presence of triethylamine and
THF. Figure 34 shows the mechanism of the reaction.

Figure 34: Mechanism reaction of compound 65

Suggested structures of compound 65 were confirmed based on the 1H NMR,
13

C NMR and IR results. The 1H NMR spectrum showed the piperazine protons of

benzimidazole around 3.43 ppm and 3.83 ppm. The N-H and O-H peaks appeared at
9.76 ppm and 11.34 ppm. In the aromatic region the benzimidazole protons appeared
at 6.9 ppm and 7.16. While the 8-Hydroxyquniolne protons appeared around at 7
ppm and 9 ppm.
The

13

C NMR spectrum showed the exact number of carbon atoms. The

carbon of piperazine appeared around 52.36 ppm and 46.47 ppm. The methyl group
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appeared at 60.04 ppm, the range of aromatic region will be 148.24- 110.43 ppm.
The IR spectrum showed N-H band at 3077 cm-1 and O-H band appeared at 3326
cm1.
4.3.2 Photochemistry
Compound 65 in aqueous solution (pH 7.4) emit cyan color (first cuvette).
The color of this emission was switched to green upon the addition of CB7 (second
cuvette), the color has then been restored with the addition of CAD (third cuvette)
(Figure 35).

Figure 35: Compound 65 (1), the complex of 65 with CB7 (2) and the complex of 65
with CB7 and CAD (3) under UV lamb

4.3.2.1 NMR titration of 65 with CB7
One of most common method for quantifying the interaction of supramolecular
components is the titration of the guest compound in the solution with the host and
tracking the changes in physical properties through NMR and UV-Vis absorption
techniques. In this work, the interaction of compound 65 with CB7 was examined,
and utilize of this supramolecular approach with CAD stimulus (as a model drug for
biosensing) was checked (Figure 36).
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Figure 36: 1H-NMR (400MHz) titration of 65 [1mM] with CB7 (0-2.9 equiv.) in
D2O at pD 2.9

In the first experiment, NMR titration was conducted in order to study the
binding mode of 65 with CB7 at pD 2.9 (potential of Deuterium). In Figure 36, in the
absence of CB7, 65 peaks were labeled a-k. (0.2, 0.4, 0.5, 1.5 and 2.9 equivalent) of
CB7 were gradually added. The upfield shift in the peaks of benzimidazole ring (a
and b) upon the increase of the CB7 equivalent.
This upfield shift also confirms the binding of CB7 to benzimidazole ring. It
is known that CB7 prefers to bind to protonated guests because of preferential iondipole interaction (Atwood et al. 2017). At pD 2.9 the benzimidazole group is
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expected to be protonated, which explains the observe NMR trend in the binding
pattern.
4.3.2.2 Host-guest interaction of the complex 65/CB7 and cadaverine
NMR titration of 65/CB7 complex at 1:2 equivalents with CAD was
conducted at acidic media in order to show the binding mode of CAD to CB7 and to
establish the stimuli-responsiveness of the host-guest system.

Figure 37: 1H-NMR aromatic region: Biding of compound 65/CB7 (1: 4.4
equiv.) with CAD (0.5 equiv.) in D2O

62

Figure 37: 1H-NMR aromatic region: Biding of compound 65/CB7 (1: 4.4
equiv.) with CAD (0.5 equiv.) in D2O (continued)

As can be seen in Figure 37, the equilibrium between compound 65 with CB7
is changed upon the addition of different equivalents. At 2.9 equivalent of CB7 the
capsulation has occurred at benzimidazole site, as manifested in the up field shifted
of a and b peaks. However with the addition of >2 equivalents, both the
benzimidazole unit and 8-HQ units were encapsulated by CB7 cavity leading to the
maximum shift of a and b peaks to 6.5 ppm and 6.3 ppm respectively. However, 8HQ protons (e - h) where not shifted at >1 equivalent of CB7, but then after adding
more than 2 equivalents of CB7 the peaks were shifted to lower ppm. The amount of
the shift depends on the monitored proton, which confirms the selectivity of this
host-guest system. For example, the CB7 prefer to initially binds to k and e protons
over the other protons (g, h and f). Table 3 shows the chemical shifts in the peaks of
compound 65, upon the addition of CB7.
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The position of the peaks a and b were recovered after the addition of CAD,
which clearly means that BZ is not encapsulated and that the CAD competes with BZ
towards the CB7 cavity. Moreover, this addition allowed the fully encapsulation of
8-HQ site. Before the addition of CAD, the CB7 was partially engulfing the 8-HQ,
but the competitive displacement of BZ by CAD enables the fully encapsulation
resulting in a full shift to lower ppm of all protons except h. Overall, the results
might be rational by the thermodynamics preference toward CAD when competing
with BZ units, which needs further investigation. While c and d protons represent the
piperazine peaks (Figure 38).

Figure 38: 1H-NMR aliphatic region: Biding of compound 65 with CB7 (0- 4.4
equiv.) and CAD (0.5 equiv.) in D2O
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Table 3: NMR chemical shift of compound 65 upon addition of CB7 and CAD
Protons

After CB7

After CAD

a

-0.8ppm

-0.8 ppm

b

-0.9 ppm

-0.9 ppm

e

-0.6 ppm

-0.8 ppm

f

-0.3 ppm

-0.6 ppm

g

-0.4 ppm

-0.8 ppm

h

-0.2 ppm

-0.5 ppm

k

-0.5 ppm

-0.9 ppm

c

+0.7 ppm

0 ppm

d

+0.5 ppm

0 ppm

Looking at aliphatic region we noticed that proton belong to the piperazine
ring and methylene group were shifted to higher ppm which indicate they are outside
the cavity, with the addition of more CB7 they are hidden under the CB7 peaks.
4.3.2.3 UV-Vis binding titration experiment
In this experiment the titration of 65/ CB7 complex with CAD was conduct
by using fluorescence techniques. In the binding titration experiment, pH 7.4 was
selected because it matches the environment in medical applications in vitro and in
vivo.

Fluorescence Intensity (a.u.)

65
250

ex= 280 nm

330 nm

pH = 7.4

200

A

CB7

150
100

460 nm
CB7

50
0
300

350

400

450

500

Wavelength / nm

Figure 39: (A) Shows the binding titration of 65 with CB7 at pH 7.4. (B) Shows the
binding titration of the complex 65 /CB7 with cadaverine at pH 7.4

Figure 39 A shows the variation the emission spectra of 65 [35 µM] upon
binding to CB7 (0-500 µM). The fluorescent compound (65) has an emission around
320, however as the CB7’s concentrations (0-500 µM) increase, the intensity at
320nm decreased and the intensity 460 nm increased. Leading to a shift in the color
from cyan to green. The appearance of an intersection points confirms the
complexion of 65 to CB7.
Figure 39 B shows the binding titration of 65 with CB7 at pH 7.4 with the
gradual addition of cadaverine to the 65/CB7. It can be noticed that there is a gradual
increase in the emission at 320nm, and with a decrease in the emission at 460nm. It
is concluded that cadaverine replaces dye 65 and restore the cyan color.
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Chapter 5: Conclusion

This study involved the design and synthesis of 17 novel compounds (57a57j), (58a-58d), 62, 63 and 65 that contain benzimidazole, piperazine, 8hydroxyqunoline and urea or thiourea moieties. Those compounds were
characterized by using suiTable spectroscopic techniques including 1H-NMR,

13

C-

NMR, and IR spectroscopy techniques.
The biological activities of the 17 synthesized compounds were evaluated for
their antibacterial and antifungal activities. The antibacterial activities were
evaluated against 6 types of bacteria (E.coli 25922, P.aereginosa 27853, Salmonella
H9812, K.pneumoniae 700603, S.aureus 25923 and Enterococcus 29212). 13
compounds (57a, 57d, 57e, 57f, 57g, 57h, 57i, 58a, 58b, 58c, 62, 63 and 65) showed
a positive result against enterococcus 29212 and 65 showed activity against
p.aereginosa 27853 and s.aureus 25923, with different concentrations ranged 33.4 96.3µg/ ml. However, all compounds showed negative results when studied against
selected four fungi (Fusarium solani, botrytis cinerea, thielaviopsis punctulate and
neoscytalidium dimidiatum) at concentration 200 µM.
Compound 65 exhibited interesting photophysical properties. Fluorescence
emission of this compound was switched from cyan to green. The establishment of
stimuli-responsiveness system emission was checked using CAD as model drug.
5.1 Recommendation and Future work
The 17 novel synthetic compounds exhibit interesting biological activity, we
evaluated only antibacterial. In the future we aim to examine antiviral,
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antihelminthic, and anticancer activities. Moreover, more compounds can be
synthesized by changing the substituent groups, in quest for future comparison.
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Appendix

Figure 40: 1H and 13C spectrum and IR for 55
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Figure 41: 1H and 13C spectrum for 56
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Figure 42: 1H and 13C spectrum for 57a
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Figure 43: 1H and 13C spectrum for 57b
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Figure 44: 1H and 13C spectrum for 57c
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Figure 45: 1H and 13C spectrum for 57d
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Figure 46: 1H and 13C spectrum for 57e
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Figure 47: 1H and 13C spectrum for 57f
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Figure 48: 1H and 13C spectrum for 57g
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Figure 49: 1H and 13C spectrum for 57h
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Figure 50: 1H and 13C spectrum for 57i
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Figure 51: 1H and 13C spectrum for 57j
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Figure 52: 1H and 13C spectrum for 58a

87

Figure 53: 1H and 13C spectrum for 58b
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Figure 54: 1H and 13C spectrum for 58c
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Figure 55: 1H and 13C spectrum for 58d
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Figure 56: 1H and 13C spectrum for 62
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Figure 57: 1H and 13C spectrum for 63
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Figure 58: 1H and 13C spectrum for 64
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Figure 59: 1H and 13C spectrum for 65
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Figure 60: Infrared spectra for (55), (56) and (57a)

95

Figure 61: Infrared spectra for (57b), (57c) and (57d)
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Figure 62: Infrared spectra for (57e), (57g) and (57f)
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Figure 63: Infrared spectra for (57h), (57i) and (57j)
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Figure 64: Infrared spectra for (58a), (58b) and (58c)
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Figure 65: Infrared spectra for (58d), (60) and (61)
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Figure 66: Infrared spectra for (62), (63) and (65)
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